GlassScriptPhysician profile
Ravi Gurujal
NPI 1467563957
$13,142.86
in general payments reported to CMS, 2019-2025
34 companies · $3,151 in 2025
The $3,151 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,403 · 2020: $822 · 2021: $1,755 · 2022: $1,685 · 2023: $1,298 · 2024: $1,029 · 2025: $3,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,000 · Travel and Lodging: $1,478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,000.17 |
| Travel and Lodging | $1,477.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,432.07 | 2020-2025 | Triclip, Mitraclip, Xience Sierra |
| Penumbra, INC. | $1,679.55 | 2019-2025 | Indigo System |
| Cardiovascular Systems INC. | $1,533.31 | 2019-2021 | |
| Boston Scientific Corporation | $1,374.88 | 2019-2024 | |
| Edwards Lifesciences Corporation | $931.52 | 2020-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Abiomed | $929.37 | 2019-2025 | Impella |
| Medtronic, INC. | $819.08 | 2021-2023 | Corevalve Evolut R |
| Angiodynamics, INC. | $576.75 | 2021-2022 | |
| W. L. Gore & Associates, INC. | $381.16 | 2020-2025 | Gore Cardioform Septal Occluder, Gore Excluder Iliac Branch Endoprosthesis |
| Shockwave Medical, INC | $359.54 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Reflow Medical INC | $318.12 | 2024-2025 | |
| Inari Medical, INC. | $243.46 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Asahi Intecc USA, INC. | $221.07 | 2024 | Peripheral Vascular |
| Atricure, INC. | $169.03 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $165.46 | 2022-2025 | Lifevest |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $139.52 | 2023 | Optimizer |
| Amgen INC. | $132.10 | 2020-2022 | |
| Cvrx, INC. | $110.70 | 2025 | Barostim Neo System |
| Recor Medical INC | $104.25 | 2025 | Paradise Ultrasound Renal Denervation System |
| Bard Peripheral Vascular, INC. | $78.73 | 2021-2022 | |
| Medtronic Vascular, INC. | $74.81 | 2019 | |
| Pfizer INC. | $74.39 | 2024-2025 | |
| Daiichi Sankyo INC. | $67.62 | 2022-2023 | Injectafer |
| Cardiva Medical, INC. | $34.78 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Astrazeneca Pharmaceuticals LP | $27.47 | 2022 | |
| Bridgebio Pharma, INC. | $24.51 | 2025 | Attruby |
| Chiesi USA, INC. | $23.96 | 2019 | |
| Heartflow, INC. | $21.50 | 2024 | |
| Altathera Pharmaceuticals LLC | $19.71 | 2024 | Sotalol Hydrochloride |
| Silk Road Medical, INC. | $18.27 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.66 | 2023 | Jardiance |
| Kls-Martin L.P. | $14.00 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $13.76 | 2025 | Eliquis |
| Lemaitre Vascular, INC. | $10.75 | 2023 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Gurujal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.